Skip to main content
eScholarship
Open Access Publications from the University of California
Refine Search

Medical Student Research Forum Posters

UC Davis

Managing Aggressive CD30-Positive Lymphoproliferative Disorder and Toward Early Palliative Care Inclusion

The data associated with this publication are not available for this reason: N/A
Abstract

Cutaneous T-Cell Lymphomas (CTCL) are rarely seen clinically, with a global annual incidence of ​<10 per 100,000, and only 11% are CD30+ Lymphoproliferative disorders (LPD). Their heterogenous clinical and pathologic presentation result in significant diagnostic challenges. Diagnosis of potentially aggressive CTCL warrants prompt clinical, histopathological, and immunohistochemical evaluation. Management of the patient with suspected CTCL, as with other life-limiting disease, should include quality of life and goals of care assessment, as well as early inclusion of palliative care in medical management.​


Top